A RANDOMISED CONTROLLED CLINICAL TRIAL OF AUTOLOGOUS STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS WITH TREATMENT REFRACTORY CROHN’S DISEASE (LOW INTENSITY THERAPY EVALUATION): ASTICLITE

James O. Lindsay  ¹     Hannah Berntsson  ²     Mike Bradburn  ²     Lauren Desoysa  ²     Shahida Din  ³     John Gribben  ³     Christopher John Hawkey  ⁴     Danny Hind  ⁴     Peter Irving  ⁵     Ellen Lee  ⁵     Yash Mahida  ⁵     Gordon Moran  ⁵     Miles Parkes  ⁶     Jack Satsangi  ⁷     Sree Subramanian  ⁸     Lizzie Swaby  ⁸     Simon Travis  ⁸     John Snowden  ⁹     Alan J Lobo  ^10    
1 Barts and the London School of Medicine, London, United Kingdom
² ScHARR, University of Sheffield, Sheffield, United Kingdom
³ Western General Hospital, Edinburgh, United Kingdom
⁴ University of Nottingham Nottingham Digest. Disease Centre Queen's Medical Centre - Queen's Medical, Nottingham, United Kingdom
⁵ Guy´s and St Thomas´ Hospital, London, United Kingdom
⁶ Inflammatory Bowel Disease Research Group, Addenbrooke's Hospital, Cambridge, UK, Cambridge, United Kingdom
⁷ Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁸ Royal Liverpool University Hospital, Liverpool, United Kingdom
⁹ Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom
¹⁰ Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom

Topic
IBD, Immunology

Session
IBD: Clinical trials IV

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)